MoonLake Immunotherapeutics (MLTX)

Sector:
FINANCE
Industry:
CORPORATE FINANCE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Bihua Chen
Employees:
2
C/O CORMORANT ASSET MANAGEMENT, LLP, 200 CLARENDON STREET FL 52, BOSTON, MA 02116
857 702 0370

We are a newly incorporated blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Data derived from most recent annual or quarterly report
Market Cap 61.32 Million Shares Outstanding11.93 Million Avg 30-day Volume 147.302 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.14
Price to Revenue0.0 Debt to Equity0.0 EBITDA-4.57 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value260.755 Million
Current Ratio0.205 EPS Growth0 Quick Ratio0.172
1 Yr BETA 0.5855 52-week High/Low 15.0 / 4.25 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score10.8799 Free Cash Flow to Firm 0
View SEC Filings from MLTX instead.

View recent insider trading info

Funds Holding MLTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MLTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-06-17:
    Item 4.01: Changes in Registrant's Certifying Accountant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-07:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2022-05-16:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-11:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.02: Unregistered Sales of Equity Securities
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
    Item 5.06: Change in Shell Company Status
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-31:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-03-24:
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-25:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-03:
    Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
  • 8-K: filed on 2021-10-04:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-05-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MOUKHEIBIR CATHERINE

    • Director
    45,000 2022-04-06 2

    XAVIER RAMNIK

    • Director
    45,000 2022-04-06 2

    STURGE SIMON

    • Director
    45,000 2022-04-06 2

    PHILLIPS ANDREW JOHN

    • Director
    45,000 2022-04-06 2

    BVF PARTNERS L P/IL

    BIOTECHNOLOGY VALUE FUND L P

    BVF I GP LLC

    BIOTECHNOLOGY VALUE FUND II LP

    BVF II GP LLC

    BIOTECHNOLOGY VALUE TRADING FUND OS LP

    BVF PARTNERS OS LTD.

    BVF GP HOLDINGS LLC

    BVF INC/IL

    LAMPERT MARK N

    • Director
    • 10% Owner
    • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
    21,691,694 2022-04-05 1

    CHEN BIHUA

    • 10% Owner
    6,065,000 2022-04-05 1

    HELIX HOLDINGS LLC

    • FORMER 10% HOLDER
    3,215,000 2022-04-05 1

    SANTOS DA SILVA JORGE CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    3,363,870 2022-04-05 1

    BODENSTEDT MATTHIAS CHIEF FINANCIAL OFFICER

    • Officer
    915,376 2022-04-05 1

    LASSEN KARA

    • Director
    0 2022-04-05 1

    LOY SPIKE

    • Director
    0 2022-04-05 1

    REICH KRISTIAN CHIEF SCIENTIFIC OFFICER

    • Officer
    3,363,870 2022-04-05 1

    CHANG NANCY T

    • Director
    0 2020-10-19 0

    SCHMID JOHN P.

    • Director
    0 2020-10-19 0

    SCOLLINS JAY CHIEF FINANCIAL OFFICER

    • Officer
    0 2020-10-19 0

    LEWIS WILL

    • Director
    0 2020-10-19 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 22:15:04 UTC -25.1899 26.7599 100
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 21:45:03 UTC -25.4647 27.0347 100
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 21:15:03 UTC -25.4647 27.0347 100
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 20:45:03 UTC -27.5095 29.0795 100
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 20:15:04 UTC -27.5095 29.0795 100
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 19:45:03 UTC -27.5095 29.0795 100
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 19:15:03 UTC -27.5095 29.0795 100
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 18:45:03 UTC -27.5095 29.0795 700
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 18:15:04 UTC -27.5095 29.0795 700
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 17:45:03 UTC -27.5095 29.0795 700
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 17:15:03 UTC -27.5095 29.0795 700
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 16:45:06 UTC -27.5095 29.0795 700
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 16:15:03 UTC -27.5095 29.0795 700
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 15:45:03 UTC -27.5095 29.0795 700
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 15:15:03 UTC -27.5095 29.0795 700
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 14:45:03 UTC -27.5095 29.0795 600
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 14:15:04 UTC -27.5095 29.0795 500
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 13:45:03 UTC -30.0825 31.6525 500
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 13:15:03 UTC -30.0825 31.6525 500
    MOONLAKE IMMUNOTHERAPEUTICS MLTX 2022-06-28 12:45:03 UTC -30.0825 31.6525 200

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments